The Hydropothecary Corporation

Marijuana activists in Arizona started the “Smart & Safe Arizona Initiative” as a ballot measure for 2020. The group gathered enough signatures.

Amid the coronavirus pandemic, marijuana has become an essential item in many US states. As a result, there was a surge in cannabis demand.

The FDA doesn’t allow CBD products to be used as a food derivative. The agency has been hesitant about how some cannabis companies market CBD products.

On Tuesday, Canopy Growth (NYSE:CGC)(TSE:WEED) announced that it will temporarily close all of its company-owned Tokyo Smoke and Tweed retail stores.

Hexo (TSE:HEXO) has been struggling for a while now. The string of bad news started in October 2019 when CFO Michael Monahan resigned.

The Tennessee Senate passed a medical marijuana bill due to the rising benefits of medical marijuana. However, the bill includes a poison pill.

Acquisitions could boost Curaleaf’s production and retail footprint significantly. With the EBITDA expected to rise over the next two years, there’s significant upside.

On January 10, HEXO was trading at 1.74 Canadian dollars, a fall of 63.1% since the beginning of 2019 and a discount of 84.6% to its 52-week high.

Cronos Group (CRON) stock rose 33% with a heavy volume in after-hours trading on Wednesday. Marijuana stocks are on a rollercoaster ride.

Cannabis demand is rising, but there seems to be a gap between cannabis demand and supply in Canada. Let’s take a closer look at the imbalance.

Aurora Cannabis (ACB) has had a tough year. The stock is down 63.1% in 2019. Let’s see how analysts have lowered their expectations for it in recent months.

Donald Trump has never openly supported marijuana legalization, and this month, Trump has shared some conflicting views on medical marijuana legalization.

Recreational marijuana is now legal in Michigan. It took the step in 2018, but the licensing process and regulations took awhile.

Cronos Group’s position in the CBD cosmetics market could be beneficial. The company is an established player in the market with the potential to grow 31%.

Jim Cramer expressed disappointment with the cannabis industry, claiming it may not be the “incredible opportunity” he thought it was.

Legal cannabis in Mexico is going through several twists and turns. The country first allowed medical marijuana in June 2017.

Cannabis is an evolving sector. Recently, Warren Buffett entered the space following Kraft Heinz’s (KHC) newest investment in Flowhub.

Aurora Cannabis (ACB) strengthened its footing in the medical cannabis industry by launching a new product. The stock rose 2.1% in pre-market trading today.

Canada’s next wave of cannabis legalization allows edibles, beverages, extracts, and topicals on October 17. The products could hit the stores in December.

HEXO stock has suffered since it reported lower-than-expected third-quarter results in June. The stock has fallen 31.8% since its earnings on June 12.

Cannabis legalization is a hot topic. With the sudden boom in the cannabis industry, legalization at the national level is vital.

HEXO reported its third-quarter earnings on June 12. The company reported revenues of $13.0 million, which fell short of analysts’ estimate.

Canopy Growth’s weak results weighed on the entire cannabis sector. Most of the cannabis stocks were in the red on Thursday.

CNN reported that heavyweight champion Mike Tyson said they smoke 10 tons of weed, worth about $40,000, at his California marijuana ranch per month.

Canopy Growth (CGC) rose 1.5% today while Cronos Group (CRON) fell 3.8%. CNBC host Jim Cramer favors both stocks amid several weed industry scandals.

Joe Biden wants to change the criminal justice system because he “believes no one should be in jail because of cannabis use.”

Before the market opened on March 28, CannTrust (CTST) reported its Q4 2018 and full-year earnings.

In the second quarter, HEXO (HEXO) had total assets of 446 million Canadian dollars, which increased year-over-year from 334 million Canadian dollars.